Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.
作者信息
Denis M
机构信息
Unité de Recherche, Hôpital Laval, Chemin Sainte-Foy, Québec, Canada.
出版信息
Infect Immun. 1991 May;59(5):1857-9. doi: 10.1128/iai.59.5.1857-1859.1991.
Abstract
Susceptible BALB/c mice were infected with Mycobacterium avium TMC 702. Groups of mice were then infused with 10(4) U (approximately 400 U/h) of murine beta interferon (IFN-beta) via a minipump system, and the progression of the infection was assessed. Mice infused with IFN-beta showed superior resistance to infection, as determined by reduced bacterial growth in the livers and spleens of infected animals, (1-log reduction in bacterial CFU at 2 months postinfection; P less than 0.001). This was corroborated by the fact that resident peritoneal macrophages treated with IFN-beta in vitro (10(2) U/ml) were more bacteriostatic for M. avium TMC 702 than their untreated counterparts. Overall, these findings suggest an important role for IFN-beta in mycobacterial infections.
摘要
相似文献
1
Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.
Infect Immun. 1991 May;59(5):1857-9. doi: 10.1128/iai.59.5.1857-1859.1991.
2
In vivo modulation of atypical mycobacterial infection: adjuvant therapy increases resistance to Mycobacterium avium by enhancing macrophage effector functions.
Cell Immunol. 1991 Apr 15;134(1):42-53. doi: 10.1016/0008-8749(91)90329-a.
3
The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.
Clin Exp Immunol. 1990 Jun;80(3):324-31. doi: 10.1111/j.1365-2249.1990.tb03288.x.
4
Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
Clin Exp Immunol. 1991 Mar;83(3):466-71. doi: 10.1111/j.1365-2249.1991.tb05662.x.
5
Modulation of Mycobacterium avium growth in murine macrophages: reversal of unresponsiveness to interferon-gamma by indomethacin or interleukin-4.
J Leukoc Biol. 1991 Jan;49(1):65-72. doi: 10.1002/jlb.49.1.65.
6
Adjuvant treatment increases the resistance to Mycobacterium avium infection of mycobacteria-susceptible BALB/c mice.
Clin Exp Immunol. 1993 Jun;92(3):466-72. doi: 10.1111/j.1365-2249.1993.tb03422.x.
7
The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex.
Clin Exp Immunol. 1999 Mar;115(3):435-42. doi: 10.1046/j.1365-2249.1999.00838.x.
8
Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis.
Infect Immun. 1999 Jul;67(7):3610-8. doi: 10.1128/IAI.67.7.3610-3618.1999.
9
Airway delivery of interferon-γ overexpressing macrophages confers resistance to Mycobacterium avium infection in SCID mice.
Physiol Rep. 2016 Nov;4(21). doi: 10.14814/phy2.13008. Epub 2016 Nov 17.
10
Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells.
Int Immunol. 1996 Aug;8(8):1299-310. doi: 10.1093/intimm/8.8.1299.
引用本文的文献
1
Activation of host nucleic acid sensors by : good for us or good for them?
Crit Rev Microbiol. 2024 Mar;50(2):224-240. doi: 10.1080/1040841X.2023.2294904. Epub 2023 Dec 28.
2
Type I interferons in tuberculosis: Foe and occasionally friend.
J Exp Med. 2018 May 7;215(5):1273-1285. doi: 10.1084/jem.20180325. Epub 2018 Apr 17.
3
IFN-β: A Contentious Player in Host-Pathogen Interaction in Tuberculosis.
Int J Mol Sci. 2017 Dec 16;18(12):2725. doi: 10.3390/ijms18122725.
4
Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences.
Front Immunol. 2017 Nov 27;8:1633. doi: 10.3389/fimmu.2017.01633. eCollection 2017.
5
cGAS-STING-TBK1-IRF3/7 induced interferon-β contributes to the clearing of non tuberculous mycobacterial infection in mice.
Virulence. 2017 Oct 3;8(7):1303-1315. doi: 10.1080/21505594.2017.1321191. Epub 2017 Apr 19.
6
Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.
Cell Mol Immunol. 2017 Jan;14(1):22-35. doi: 10.1038/cmi.2016.25. Epub 2016 Jun 6.
7
Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.
PLoS Pathog. 2015 Aug 7;11(8):e1005040. doi: 10.1371/journal.ppat.1005040. eCollection 2015 Aug.
8
Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection--the double-edged sword?
Biomed Res Int. 2013;2013:179174. doi: 10.1155/2013/179174. Epub 2013 Nov 12.
9
Interferon alpha treatment of patients with impaired interferon gamma signaling.
J Clin Immunol. 2013 Jul;33(5):991-1001. doi: 10.1007/s10875-013-9882-5. Epub 2013 Mar 20.
10
Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis.
J Immunol. 2012 Jun 15;188(12):6205-15. doi: 10.4049/jimmunol.1200255. Epub 2012 May 7.
本文引用的文献
1
Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.
Proc Natl Acad Sci U S A. 1984 Feb;81(3):908-12. doi: 10.1073/pnas.81.3.908.
2
The protective role of endogenous interferon in viral, bacterial, and protozoal infections.
Antiviral Res. 1985;Suppl 1:173-83. doi: 10.1016/s0166-3542(85)80026-7.
3
Comparative biology of intracellular parasitism.
Microbiol Rev. 1985 Sep;49(3):298-337. doi: 10.1128/mr.49.3.298-337.1985.
4
The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey.
Am Rev Respir Dis. 1987 May;135(5):1007-14. doi: 10.1164/arrd.1987.135.5.1007.
5
Antibacterial activity of recombinant murine beta interferon.
Infect Immun. 1988 Mar;56(3):548-51. doi: 10.1128/iai.56.3.548-551.1988.
6
The effect of gamma-interferon during Mycobacterium bovis (BCG) infection in athymic and euthymic mice.
Microb Pathog. 1986 Apr;1(2):221-4. doi: 10.1016/0882-4010(86)90024-0.
7
Interferon-gamma, the activated macrophage, and host defense against microbial challenge.
Ann Intern Med. 1988 Apr;108(4):595-608. doi: 10.7326/0003-4819-108-4-595.
8
9
Control of the Bcg gene of early resistance in mice to infections with BCG substrains and atypical mycobacteria.
Clin Exp Immunol. 1986 Mar;63(3):517-25.
10
The enhancing effect of interferon-beta and -gamma on the killing of Leishmania tropica major in human mononuclear phagocytes in vitro.
J Immunol. 1986 Apr 15;136(8):3062-6.
Zotero 插件